Envista Holdings Corporation (NVST) is listed on NYSE in Medical Device Stocks. It is $27.14, -1.11%, with a $4.4B market cap. RSI is 48.2, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 48.2 Neutral
Market Cap $4.4B
Volume 947.2K
Fundamentals — 10-Q Q2 2026
Revenue $1.4B
Net Income $92.4M
EPS $0.56
Gross Margin 55.5%
Operating Margin 9.9%
Net Margin 6.4%
Debt / Equity 0.5x
P/E Ratio 48.5x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Reis Mischa | SVP, Strategy & Bus. Dev. | Sell | 8,000 | $27.50 | $220,000 | 2026 Aug 20 |
| Reis Mischa | SVP, Strategy & Bus. Dev. | Sell | 15,000 | $21.60 | $324,000 | 2025 Aug 25 |
| Keel Paul A | Chief Executive Officer | Buy | 30,000 | $16.87 | $506,100 | 2024 Aug 13 |
| Hammes Eric D. | Chief Financial Officer | Buy | 24,532 | $16.33 | $400,608 | 2024 Aug 12 |
| Conley Eric | SVP, Orthodontics | Buy | 2,185 | $22.89 | $50,015 | 2023 Nov 16 |
| Nance Mark E | General Counsel | Buy | 5,000 | $21.75 | $108,750 | 2023 Nov 8 |
| Aghdaei Amir | Chief Executive Officer | Buy | 10,000 | $21.53 | $215,253 | 2023 Nov 6 |
| Keller Stephen | Principal Financial Officer | Buy | 2,000 | $21.53 | $43,060 | 2023 Nov 6 |
| Yu Howard H | Chief Financial Officer | Sell | 10,016 | $37.90 | $379,606 | 2023 Feb 28 |
| Yu Howard H | Chief Financial Officer | Sell | 657 | $36.55 | $24,013 | 2022 Nov 17 |
| Yu Howard H | Chief Financial Officer | Sell | 5,341 | $45.73 | $244,244 | 2022 Apr 18 |
| Aghdaei Amir | Chief Executive Officer | Sell | 10,538 | $51.66 | $544,391 | 2022 Mar 29 |
| Aghdaei Amir | Chief Executive Officer | Sell | 125,240 | $50.75 | $6.4M | 2022 Mar 21 |
| Yu Howard H | Chief Financial Officer | Sell | 24,538 | $50.20 | $1.2M | 2022 Mar 21 |
| Reis Mischa | SVP, Strategy & Bus. Dev. | Sell | 10,092 | $50.00 | $504,600 | 2022 Mar 18 |
| Aghdaei Amir | Chief Executive Officer | Sell | 128,752 | $48.86 | $6.3M | 2022 Mar 17 |
| Reis Mischa | SVP, Strategy & Bus. Dev. | Sell | 2,958 | $47.83 | $141,481 | 2022 Mar 1 |
| Bludworth Curt W | Chief Human Resources Officer | Sell | 4,181 | $47.83 | $199,977 | 2022 Mar 1 |
| Reis Mischa | SVP, Strategy & Bus. Dev. | Sell | 4,278 | $47.71 | $204,103 | 2022 Feb 25 |
| Yu Howard H | Chief Financial Officer | Sell | 3,598 | $47.81 | $172,020 | 2022 Feb 25 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $48.52 | 73.0 | $2.5B |
| | $8.44 | 51.9 | $2.2B |
Take NVST further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put NVST in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Envista Holdings Corporation next reports.
Set alerts on NVST
Get notified when Envista Holdings Corporation hits your price targets or technical conditions are met.
Get Started Free